Published in World J Gastroenterol on January 28, 2009
Environment and the inflammatory bowel diseases. Can J Gastroenterol (2013) 1.07
Genetic loci involved in antibody response to Mycobacterium avium ssp. paratuberculosis in cattle. PLoS One (2010) 1.03
Macrophage-related diseases of the gut: a pathologist's perspective. Virchows Arch (2012) 0.96
Detection of Mycobacterium avium subsp. paratuberculosis in drinking water and biofilms by quantitative PCR. Appl Environ Microbiol (2010) 0.95
Mycobacterium avium paratuberculosis and the etiology of Crohn's disease: a review of the controversy from the clinician's perspective. Can J Gastroenterol (2010) 0.94
High prevalence of viable Mycobacterium avium subspecies paratuberculosis in Crohn's disease. World J Gastroenterol (2010) 0.93
Matrix metalloproteinases in inflammatory bowel disease: an update. Mediators Inflamm (2015) 0.87
A novel real-time PCR assay for specific detection and quantification of Mycobacterium avium subsp. paratuberculosis in milk with the inherent possibility of differentiation between viable and dead cells. BMC Res Notes (2010) 0.84
Pathogenesis of Crohn's disease: Bug or no bug. World J Gastrointest Pathophysiol (2015) 0.84
Highly specific and quick detection of Mycobacterium avium subsp. paratuberculosis in feces and gut tissue of cattle and humans by multiple real-time PCR assays. J Clin Microbiol (2011) 0.82
Optimization of a rapid viability assay for Mycobacterium avium subsp. paratuberculosis by using alamarBlue. Appl Environ Microbiol (2009) 0.81
Serum antibodies to Mycobacterium avium subspecies paratuberculosis combined with anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients: prevalence and diagnostic role. Dig Dis Sci (2011) 0.81
Presence of intestinal Mycobacterium avium subspecies paratuberculosis (MAP) DNA is not associated with altered MMP expression in ulcerative colitis. BMC Gastroenterol (2011) 0.81
Immunopathogenesis of granulomas in chronic autoinflammatory diseases. Clin Transl Immunology (2016) 0.80
Resolution of Crohn's disease and complex regional pain syndrome following treatment of paratuberculosis. World J Gastroenterol (2015) 0.79
The Mycobacterium avium ssp. paratuberculosis specific mptD gene is required for maintenance of the metabolic homeostasis necessary for full virulence in mouse infections. Front Cell Infect Microbiol (2014) 0.79
Lactase persistence, NOD2 status and Mycobacterium avium subsp. paratuberculosis infection associations to Inflammatory Bowel Disease. Gut Pathog (2012) 0.79
Persistence of bacterial indicators and zoonotic pathogens in contaminated cattle wastes. BMC Microbiol (2016) 0.78
In Vivo Volatile Organic Compound Signatures of Mycobacterium avium subsp. paratuberculosis. PLoS One (2015) 0.78
Species-specific engagement of human nucleotide oligomerization domain 2 (NOD)2 and Toll-like receptor (TLR) signalling upon intracellular bacterial infection: role of Crohn's associated NOD2 gene variants. Clin Exp Immunol (2015) 0.77
Avian Mycobacteriosis: Still Existing Threat to Humans. Biomed Res Int (2016) 0.77
Crohn's disease: evidence for involvement of unregulated transcytosis in disease etio-pathogenesis. World J Gastroenterol (2011) 0.76
Responses of Bovine Innate Immunity to Mycobacterium avium subsp. paratuberculosis Infection Revealed by Changes in Gene Expression and Levels of MicroRNA. PLoS One (2016) 0.75
Isolation and identification of nontuberculous mycobacteria from hospitalized patients and drinking water samples-examination of their correlation by chemometrics. Environ Monit Assess (2016) 0.75
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature (2001) 33.12
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science (2006) 27.49
A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet (2006) 15.14
Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet (2007) 13.74
Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell (2004) 12.71
Microbial influences in inflammatory bowel diseases. Gastroenterology (2008) 9.20
Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. Lancet (2004) 6.84
Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease. Gastroenterology (2007) 5.40
Is Crohn's disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's disease. Lancet Infect Dis (2003) 3.42
Detection and verification of Mycobacterium avium subsp. paratuberculosis in fresh ileocolonic mucosal biopsy specimens from individuals with and without Crohn's disease. J Clin Microbiol (2003) 3.09
Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis. Lancet Infect Dis (2007) 2.85
Spheroplastic phase of mycobacteria isolated from patients with Crohn's disease. J Clin Microbiol (1986) 2.55
Causation of Crohn's disease by Mycobacterium avium subspecies paratuberculosis. Can J Gastroenterol (2000) 2.18
Detection of Mycobacterium avium subspecies paratuberculosis from patients with Crohn's disease using nucleic acid-based techniques: a systematic review and meta-analysis. Inflamm Bowel Dis (2008) 2.12
Johne's disease, inflammatory bowel disease, and Mycobacterium paratuberculosis. Annu Rev Microbiol (2004) 1.98
Isolation of Mycobacterium avium subsp paratuberculosis from breast milk of Crohn's disease patients. Am J Gastroenterol (2000) 1.83
Mycobacterium avium subsp. paratuberculosis, genetic susceptibility to Crohn's disease, and Sardinians: the way ahead. J Clin Microbiol (2005) 1.82
Integrating theories of the etiology of Crohn's disease. On the etiology of Crohn's disease: questioning the hypotheses. Med Sci Monit (2006) 1.74
The mycobacteria story in Crohn's disease. Am J Gastroenterol (2005) 1.71
A meta-analysis of antimycobacterial therapy for Crohn's disease. Am J Gastroenterol (2000) 1.54
Does Mycobacterium avium subspecies paratuberculosis cause Crohn's disease? Gut (2005) 1.51
High prevalence of Mycobacterium avium subspecies paratuberculosis IS900 DNA in gut tissues from individuals with Crohn's disease. Gut (2005) 1.51
The evidence for Mycobacterium paratuberculosis in Crohn's disease. Curr Opin Gastroenterol (2008) 1.47
CARD15/NOD2 is required for Peyer's patches homeostasis in mice. PLoS One (2007) 1.41
Johne's disease in Canada Part I: clinical symptoms, pathophysiology, diagnosis, and prevalence in dairy herds. Can Vet J (2006) 1.36
Inflammatory bowel disease: progress and current concepts of etiopathogenesis. J Dig Dis (2007) 1.30
Molecular pathogenesis of inflammatory bowel disease: genotypes, phenotypes and personalized medicine. Ann Med (2007) 1.29
Mycobacterium paratuberculosis is recognized by Toll-like receptors and NOD2. J Leukoc Biol (2007) 1.22
Bacterial DNA within granulomas of patients with Crohn's disease--detection by laser capture microdissection and PCR. Am J Gastroenterol (2004) 1.21
On the action of methotrexate and 6-mercaptopurine on M. avium subspecies paratuberculosis. PLoS One (2007) 1.14
Relationship between Crohn's disease, infection with Mycobacterium avium subspecies paratuberculosis and SLC11A1 gene polymorphisms in Sardinian patients. World J Gastroenterol (2006) 1.09
Mycobacterium avium ssp. paratuberculosis and its potential survival tactics. Lett Appl Microbiol (2006) 1.08
Specific seroreactivity of Crohn's disease patients against p35 and p36 antigens of M. avium subsp. paratuberculosis. Vet Microbiol (2000) 1.08
Epidemiological evidence for Mycobacterium avium subspecies paratuberculosis as a cause of Crohn's disease. Epidemiol Infect (2007) 1.03
Thiopurine drugs azathioprine and 6-mercaptopurine inhibit Mycobacterium paratuberculosis growth in vitro. Antimicrob Agents Chemother (2007) 1.00
Role of bacteria in the etiopathogenesis of inflammatory bowel disease. World J Gastroenterol (2007) 0.97
Microbial mannan inhibits bacterial killing by macrophages: a possible pathogenic mechanism for Crohn's disease. Gastroenterology (2007) 0.96
Application of the genome sequence to address concerns that Mycobacterium avium subspecies paratuberculosis might be a foodborne pathogen. Foodborne Pathog Dis (2004) 0.93
Crohn's disease in people exposed to clinical cases of bovine paratuberculosis. Epidemiol Infect (2006) 0.89
Influence of type of culture medium on characterization of Mycobacterium avium subsp. paratuberculosis subtypes. J Clin Microbiol (2007) 0.86
Testing the interaction between NOD-2 status and serological response to Mycobacterium paratuberculosis in cases of inflammatory bowel disease. J Clin Microbiol (2007) 0.85
Antimycobacterial therapy in Crohn's disease: game over? Gastroenterology (2007) 0.84
CCFA microbial-host interactions workshop: highlights and key observations. Inflamm Bowel Dis (2007) 0.81
[Extraintestinal manifestations in inflammatory bowel disease: differences between Crohn's disease and ulcerative colitis]. Med Clin (Barc) (2005) 2.90
MDR1 gene: susceptibility in Spanish Crohn's disease and ulcerative colitis patients. Inflamm Bowel Dis (2006) 1.54
Mucosal healing for predicting clinical outcome in patients with ulcerative colitis using thiopurines in monotherapy. Eur J Intern Med (2011) 1.48
Translation, cultural adaptation and validation of a Spanish version of the Irritable Bowel Syndrome Severity Score. Rev Esp Enferm Dig (2011) 1.38
Myenteric antiplexus antibodies and class II HLA in achalasia. Dig Dis Sci (2002) 1.21
Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype. Eur J Gastroenterol Hepatol (2003) 1.20
Relation of IL28B gene polymorphism with biochemical and histological features in hepatitis C virus-induced liver disease. PLoS One (2012) 1.09
Role of the MHC2TA gene in autoimmune diseases. Ann Rheum Dis (2006) 1.06
Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans. Pharmacogenomics (2006) 1.02
CD40: novel association with Crohn's disease and replication in multiple sclerosis susceptibility. PLoS One (2010) 1.01
Role of the PXR gene locus in inflammatory bowel diseases. Inflamm Bowel Dis (2007) 1.00
Prevalence of atypical symptoms and their association with typical symptoms of gastroesophageal reflux in Spain. Eur J Gastroenterol Hepatol (2006) 0.98
Association of the organic cation transporter OCTN genes with Crohn's disease in the Spanish population. Eur J Hum Genet (2006) 0.96
Specific association of a CLEC16A/KIAA0350 polymorphism with NOD2/CARD15(-) Crohn's disease patients. Eur J Hum Genet (2009) 0.96
Splitting irritable bowel syndrome: from original Rome to Rome II criteria. Am J Gastroenterol (2004) 0.95
Influence of the inducible nitric oxide synthase gene (NOS2A) on inflammatory bowel disease susceptibility. Immunogenetics (2007) 0.93
IL23R and IL12B polymorphisms in Spanish IBD patients: no evidence of interaction. Inflamm Bowel Dis (2008) 0.93
High prevalence of viable Mycobacterium avium subspecies paratuberculosis in Crohn's disease. World J Gastroenterol (2010) 0.93
Novel association of the interleukin 2-interleukin 21 region with inflammatory bowel disease. Am J Gastroenterol (2009) 0.92
Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria. Pharmacoeconomics (2002) 0.92
Predicting response to therapy in chronic hepatitis C: an approach combining interleukin-28B gene polymorphisms and clinical data. J Gastroenterol Hepatol (2012) 0.91
Role of ATG16L1 Thr300Ala polymorphism in inflammatory bowel disease: a Study in the Spanish population and a meta-analysis. Inflamm Bowel Dis (2009) 0.89
Polymorphism of the TLR4 gene reduces the risk of hepatitis C virus-induced hepatocellular carcinoma. Oncology (2012) 0.86
Influence of psychological distress on characteristics of symptoms in patients with GERD: the role of IBS comorbidity. Dig Dis Sci (2008) 0.86
Prevalence of functional gastrointestinal disorders in patients with fibromyalgia and the role of psychologic distress. Clin Gastroenterol Hepatol (2008) 0.84
Polymorphisms in the selenoprotein S gene: lack of association with autoimmune inflammatory diseases. BMC Genomics (2008) 0.83
Severity of ulcerative colitis is associated with a polymorphism at diamine oxidase gene but not at histamine N-methyltransferase gene. World J Gastroenterol (2006) 0.83
Polymorphisms in the transforming growth factor-beta gene (TGF-beta) and the risk of advanced alcoholic liver disease. Liver Int (2005) 0.82
Polymorphisms of the glutathione S-transferases mu-1 (GSTM1) and theta-1 (GSTT1) and the risk of advanced alcoholic liver disease. Scand J Gastroenterol (2005) 0.82
Glutathione S-transferase M1 and T1 genetic polymorphisms are not related to the risk of hepatocellular carcinoma: a study in the Spanish population. Eur J Cancer (2005) 0.82
Study of chromosomal region 5p13.1 in Crohn's disease, ulcerative colitis, and rheumatoid arthritis. Hum Immunol (2010) 0.81
Analysis of the REL polymorphism rs13031237 in autoimmune diseases. Ann Rheum Dis (2010) 0.81
The burden and management of patients with IBS: Results from a survey in spanish gastroenterologists. Rev Esp Enferm Dig (2011) 0.80
GSTT1 and GSTM1 null genotypes may facilitate hepatitis C virus infection becoming chronic. J Infect Dis (2007) 0.80
FcRL3 gene promoter variant is associated with peripheral arthritis in Crohn's disease. Inflamm Bowel Dis (2009) 0.78
Non-invasive evaluation of the fibrosis stage in chronic hepatitis C: a comparative analysis of nine scoring methods. Scand J Gastroenterol (2010) 0.78
[Utility of liver biopsy in the etiologic diagnosis of biochemical liver abnormalities of unknown cause]. Gastroenterol Hepatol (2007) 0.78
Genetic markers linked to rheumatoid arthritis are also strongly associated with articular manifestations in ulcerative colitis patients. Hum Immunol (2006) 0.78
Using of magnetic resonance enterography in the management of Crohn's disease of the small intestine: first year of experience. Rev Esp Enferm Dig (2012) 0.78
MDR1 polymorphisms and response to azathioprine therapy in patients with Crohn's disease. Inflamm Bowel Dis (2007) 0.77
Glutathione S-transferases pi 1, alpha 1 and M3 genetic polymorphisms and the risk of hepatocellular carcinoma in humans. Pharmacogenomics (2007) 0.77
A recombined haplotype in the major histocompatibility region contains a cluster of genes conferring high susceptibility to ulcerative colitis in the Spanish population. Inflamm Bowel Dis (2005) 0.76
Adalimumab reversed a severe lymphopenia in a patient with Crohn's disease. J Crohns Colitis (2011) 0.76
Strong protective effect of DR3 against ulcerative colitis in the Spanish population. Am J Gastroenterol (2007) 0.76
Polymorphisms in interleukin-10 gene according to mutations of NOD2/CARD15 gene and relation to phenotype in Spanish patients with Crohn's disease. World J Gastroenterol (2006) 0.76
Is the reflux disease questionnaire useful for identifying GERD according to the Montreal definition? BMC Gastroenterol (2014) 0.75
Analysis of a non-synonymous single nucleotide polymorphism of the human diamine oxidase gene (ref. SNP ID: rs1049793) in patients with Crohn's disease. Scand J Gastroenterol (2009) 0.75
"12 weeks' stopping rule" in the treatment of genotype 1 chronic hepatitis C: two prognostic categories under the same label? Scand J Gastroenterol (2008) 0.75
[Therapeutic update in hepatitis C]. Rev Esp Quimioter (2015) 0.75
A computer-assisted morphometric quantitative analysis of iron overload in liver biopsies. A comparison with histological and biochemical methods. Pathol Res Pract (2005) 0.75
Conclusions of the II International and IV Spanish Hydration Congress. Toledo, Spain, 2nd-4th December, 2015. Nutr Hosp (2016) 0.75